Gergely Agócs

Mr. Gergely Agócs

orcid
Pharm.D. Ph.D.

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2025 in Clinical Oral Implants Research
Verified
Journal Article
Open access
KMKrisztina Mikulás
Krisztina Mikulás
XQXinyi Qian
Xinyi Qian
PTPéter Tajti
Péter Tajti
Gergely AgócsGergely Agócs
Gergely Agócs
GGGerman O. Gallucci
German O. Gallucci
PHPéter Hermann
Péter Hermann
Background: Accurately replicating the emergence profile (EP) of conditioned soft tissue is pivotal for the success of implant‐supported restorations. In the field of digital technology, various methods have emerged to capture EP. This review aims to critically assess current digital methodologies for capturing peri‐implant EP.Material and Methods: Prospective interventional or observational clinical studies focusing on digitally mapping the emergence profile (EP) around single implant‐supported restorations were included. Systematic reviews, in vitro and animal studies, and those not emphasizing EP capture were excluded. A systematic search across four databases (MEDLINE, CENTRAL, Embase, Web of Science) was conducted on 7th August 2024 based on a previously registered protocol (PROSPERO registration number: CRD42023459484). Risk of bias was assessed with RoB 2, ROBINS‐I, and JBI critical appraisal tools. Qualitative and quantitative analyses were carried out.Results: Twenty‐four eligible studies were identified, comprising 5 dental techniques, 12 case reports, 1 randomized controlled study, 2 cross‐sectional studies, and 4 cross‐over studies. The studies reported semi‐digital pathways, direct scanning, indirect scanning, coded‐healing abutments, and individualized use of scan bodies. Notably, the direct scanning technique showed considerable soft tissue collapse. Similar results can be achieved with indirect scanning and the conventional method.Conclusions: Indirect EP scanning appears as the most promising method for capturing peri‐implant EP. However, a confirmation of this finding requires a quantitative analysis through randomized clinical trials.


20 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MHMárk Hernádfői
Márk Hernádfői
MSMárton Szabados
Márton Szabados
EBEdit Brückner
Edit Brückner
ÁVÁgnes Varga
Ágnes Varga
Peter HauserPeter Hauser
Peter Hauser
Miklós GaramiMiklós Garami
Miklós Garami
Background/Objectives: The anti-GD2 monoclonal antibody dinutuximab beta has become standard of care maintenance therapy for high-risk neuroblastoma (HR-NB) in the first-line setting and is also approved in the relapsed/refractory setting. We present a retrospective review of 37 children with HR-NB included in the Hungarian Childhood Cancer Registry who received dinutuximab beta (first-line maintenance therapy, n = 31; relapsed/refractory, n = 6). Methods: All patients received dinutuximab beta continuously over the first 10 days of each 35-day cycle, with dosing based on body surface area/weight. Five cycles were planned, with further cycles administered at the treating physician’s discretion. Results: At data cutoff, the overall disease control rate was 54.1% (20/37) (complete response, 51.4% (19/37); partial response, 0.0% (0/37), stable disease, 2.7% [1/37]); two patients (5.4%) had progressive disease, and 15 patients (40.5%) had died. The 5-year overall survival (OS) and event-free survival (EFS) rates in the overall population were 63.3% (95% confidence interval, 49.1−81.7) and 56.2% (95% confidence interval, 42.1−75.0), respectively. Grade 3 or 4 adverse events (including blood and lymphatic system disorders, hypoxia, hypotension, and capillary leak syndrome) were generally consistent with dinutuximab beta’s known safety profile. Conclusions: Dinutuximab beta was an effective immunotherapy for patients with HR-NB in routine clinical practice, with a generally manageable side effect profile.

17 November 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
JKJozsef Kelemen
Jozsef Kelemen
MSMarton Sztermen
Marton Sztermen
KDKrisztina Éva Dakos
Krisztina Éva Dakos
Gergely AgócsGergely Agócs
Gergely Agócs
JBJozsef Budai
Jozsef Budai
LELoránd Erõss
Loránd Erõss
Background: An external ventricular drain (EVD) is used to release elevated intracranial pressure by draining cerebrospinal fluid (CSF) from the brain’s ventricles. The establishment of an EVD is one of the most commonly performed neurosurgical procedures to treat intracranial pressure in patients. Nevertheless, infections are very frequent complications. Identifying the risk factors for EVD-related infections is a key to improving patient safety and outcomes. Methods: We conducted a retrospective, single-center study of patients who underwent EVD implantation between January 2022 and March 2024. Patients were classified into infected and non-infected groups based on their clinical symptoms, as well as laboratory and microbiological results. Patient characteristics and possible risk factors for infection were compared between the two groups. Results: In total, 123 patients treated with 156 EVDs were included in this study, with a mean age of 55.8 (range: 25–84) years. EVD-associated infections were observed in 37 patients (30%). We found no significant association between infection risk and patient characteristics, including gender, primary diagnosis, craniotomy, or immunosuppression. There was no significant difference in terms of EVD insertion, i.e., whether the insertion took place in the operating room (OR) with antibiotic prophylaxis or outside the OR with no periprocedural antibiotic treatment. However, within the intensive care unit (ICU), EVD infection was much lower (13%) if EVD insertion took place in a single-bed room compared to multiple-bed room insertions (34%). Furthermore, there were significant differences in terms of the duration of first EVD (both single and multiple catheterizations) (p < 0.0001) and the total catheterization time (p = 0.0001). Additionally, there was a significant association with patient days in the ICU and EVD catheterization. Conclusions: Revisiting infection control measures is necessary, with special attention to the replacement of EVDs in single-bed ICU rooms, to introduce antibiotic prophylaxis in the ICU. Minimizing unnecessary EVD manipulation during catheterization is crucial in order to decrease the risk of EVD infection.

6 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ENElias-Leon Nolden
Elias-Leon Nolden
BGBruna Guimarães
Bruna Guimarães
KBKatarina Sofia Barkovskij-Jakobsen
Katarina Sofia Barkovskij-Jakobsen
AWAlexander Schulze Wenning
Alexander Schulze Wenning
BSBoglárka Lilla Szentes
Boglárka Lilla Szentes
MVMihály Vaszilkó
Mihály Vaszilkó
Background/Objectives: Cranioplasty (CP) is associated with high complication rates (20–50%), and the optimal choice between patient-specific implants (PSIs) and hand-molded (HM) alternatives remains debated. This systematic review and meta-analysis aims to compare surgical and postoperative outcomes between PSIs and HM implants. Methods: A systematic search was performed in three databases to identify studies reporting surgical site infection (SSI), implant removal, reoperation, operative time or cosmetic outcome for PSIs and/or HM implants. Two-arm studies of the same material were analyzed separately from pooled single- and two-arm studies. Results: 125 observational studies involving 10,034 patients were included. In two-arm comparisons, PSIs reduced implant removal for titanium (OR 0.34, p = 0.053) and PMMA (OR 0.56, p = 0.188), while SSI rates showed no meaningful difference between groups. In one-arm analyses, PSIs demonstrated lower explantation probabilities (titanium 6.1%, PMMA 7.9%) compared with HM alternatives (titanium 9.9%, PMMA 14.2%), alongside shorter operation times and fewer reoperations. Cosmetic outcomes consistently favored PSIs. Conclusions: PSIs demonstrate advantages in efficiency, durability, and esthetics compared with HM implants, supporting their preferential use where resources allow. HM implants remain a cost-effective option in resource-limited settings. Due to the observational nature of the included studies and differences in study populations across arms, the findings should be interpreted with caution.

25 July 2024 in Journal of Orthopaedic Translation
Verified
Journal Article
Open access
GSGyula Ferenc Szőcs
Gyula Ferenc Szőcs
SVSzilárd Váncsa
Szilárd Váncsa
Gergely AgócsGergely Agócs
Gergely Agócs
Peter HegyiPeter Hegyi
Peter Hegyi
DMDora Matis
Dora Matis
GHGyörgy Márk Hangody
György Márk Hangody
Currently, it is advised to perform meniscal repair instead of meniscectomy in certain cases of primary anterior cruciate ligament reconstruction (ACLR). However, the level of evidence is low. Therefore, this study aimed to compare the effectiveness of meniscectomy and meniscus repair in addition to ACLR. The systematic search was conducted in three online databases (EMBASE, MEDLINE, and Cochrane) from inception until October 2021 for the literature on primary ACLR and concomitant meniscal surgery. Eligible studies compared the following outcomes between meniscal repair and meniscectomy groups: the Knee injury and Osteoarthritis Outcome Score (KOOS), Lysholm score, International Knee Documentation Committee (IKDC) score, and KT-arthrometer examinations. Lastly, we calculated pooled mean differences (MDs) with 95 % confidence intervals (CIs) from the change between pre- and post-intervention values. Of 10,565 studies, 22 met the inclusion criteria, with a follow-up between 6 and 43 months. We found no difference when comparing the KOOS subscale changes—only in the KOOS pain subscale (MD = −1.6; CI: −2.48, −0.72). However, these results were not clinically significant. We analyzed the lateral and media meniscal injuries separately and concluded the same results regarding KOOS changes. We found no significant differences in the Lysholm score change (MD = −2.61; CI: −5.51, 0.29), changes in IKDC score (MD = 1.08; CI: −4.05, 6.21) or the change for the KT-arthrometer side-to-side difference (MD = −0.50; CI: −1.06, 0.06). Based on our result, we did not find a clinically significant difference between meniscus repair and meniscectomy during primary ACLR regarding patient-reported outcomes in a short-term follow-up. Our research supports the prompt integration of findings into clinical practice for treating meniscus injuries during ACL reconstruction. We recommend considering both meniscus repair and meniscectomy, as the available data indicate their effectiveness. Further studies are necessary to assess the long-term impacts, particularly on osteoarthritis, and to identify patient subgroups that may benefit most from each technique.